In yesterday’s Wall Street session, CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares traded at $0.05, down -9.98% from the previous session.
CERO stock price is now -59.85% away from the 50-day moving average and -91.69% away from the 200-day moving average. The market capitalization of the company currently stands at $7.88M.
In other news, YK Bioventures Opportunities G, 10% Owner sold 2,998,908 shares of the company’s stock on Dec 13 ’24. The stock was sold for $179,934 at an average price of $0.06. Upon completion of the transaction, the 10% Owner now directly owns 13,005,169 shares in the company, valued at $0.65 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 12 ’24, 10% Owner YK Bioventures Opportunities G sold 1,614,541 shares of the business’s stock. A total of $113,018 was realized by selling the stock at an average price of $0.07. This leaves the insider owning 16,004,077 shares of the company worth $0.8 million. A total of 48.16% of the company’s stock is owned by insiders.
During the past 12 months, CERo Therapeutics Holdings Inc has had a low of $0.05 and a high of $12.80. The fifty day moving average price for CERO is $0.12674 and a two-hundred day moving average price translates $0.62712 for the stock.
The latest earnings results from CERo Therapeutics Holdings Inc (NASDAQ: CERO) was released for 2024-06-30. The company reported revenue of $4.4 million for the quarter, compared to $1.54 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 186.59 percent.
